Hawaii Island Stem Cell Therapy expands regenerative care across three clinics

Hawaii Island Stem Cell Therapy and Regenerative Medicine is widening its orthobiologic and cell-signaling options at clinics in Pahoa, Kona and Maui. The move is aimed at patients across Hawaii who want non-surgical treatment after trying more conservative care without lasting relief.

Why it matters: - The expansion gives Hawaii patients more non-surgical regenerative medicine choices on the Big Island, Maui and in Kona. - The clinic is adding options for people seeking alternatives after physical therapy and medication have not helped enough. - The new offering includes more information on the practice's expanded services and consultation process.

What happened: - Hawaii Island Stem Cell Therapy and Regenerative Medicine expanded its regenerative medicine offerings at its clinic locations in Pahoa, Kona and Maui. - Dr. Christopher Lawinski leads the practice. - The practice says the expansion broadens the range of orthobiologic and cell-signaling options available to patients. - The clinic is part of the Hawaii Whole Person Healing Collective.

The details: - Dr. Lawinski earned his medical degree from the University of Pennsylvania School of Medicine. - He completed his family medicine residency at the University of Hawaii on Oahu. - Dr. Lawinski opened the Pahoa practice in 2010. - He performed his first orthobiologic injection in 2015 using platelets from a patient's blood and material from the patient's adipose tissue. - The practice has used ultrasound guidance for the past six years to place injections with what Dr. Lawinski describes as pinpoint precision. - Orthobiologic material is described as material with biologic activity that stimulates the body's healing response. - Autologous orthobiologics come from the patient's own body, including platelets and stem cells drawn from blood or fat tissue and reinjected at the site of injury. - Dr. Lawinski says autologous treatment has the clearest regulatory standing, though patients may experience temporary increased inflammation and some added discomfort after the procedure. - Donor-derived material is manufactured and available off the shelf, which removes the need for a separate collection procedure beforehand. - The practice's newest offering is Regenerative Protein Array, or RPA, an acellular, non-DNA regenerative product supplied by Genesis Regenerative. - The practice also offers ozone therapy, chelation therapy, nutritional IV therapy, peptide therapy, bioidentical hormone treatment, hyperbaric treatment, red laser therapy and inhalational hydrogen therapy. - The clinic says procedures are minimally invasive. - Most patients are able to drive themselves home afterward.

Between the lines: - The expansion reflects a broader shift in orthopedic care toward orthobiologics and donor-derived products. - Dr. Lawinski says the field of orthobiologics is undergoing a revolution. - The clinic is positioning its regenerative medicine work alongside functional and integrative medicine rather than as a standalone service line. - Patient demand appears to be driven by people who want to avoid surgery but still need more than conservative care can provide.

What's next: - Patients start with an initial consultation to review candidacy and care options. - The clinic then schedules a treatment visit if appropriate. - Hawaii Island Stem Cell Therapy and Regenerative Medicine is directing patients to its website to learn more or schedule a consultation. - More information is available at the practice website and Dr. Lawinski's profile.

The bottom line: - Hawaii Island Stem Cell Therapy is expanding its regenerative medicine menu to serve more Hawaii patients looking for minimally invasive, non-surgical care.